Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus (original) (raw)

References

  1. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons — Florida and New York, 1988–1991. Mortal. Morbid. Weekly Rep. 40, 585–591 (1991).
  2. Block, A.B. et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 271, 665–671 (1994).
    Article Google Scholar
  3. Bloom, B.R. & Murray, C.J.L. Tuberculosis: Commentary on a reemergent killer. Science 257, 1055–1064 (1992).
    Article CAS Google Scholar
  4. Zhang, Y., Heym, B., Alien, B., Young, D. & Cole, S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358, 591–593 (1992).
    Article CAS Google Scholar
  5. Banerjee, A. et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263, 227–230 (1994).
    Article CAS Google Scholar
  6. Telenti, A. et al. Detection of rifampicin-resistant mutations in Mycobacterium tuberculosis. Lancet 341, 647–650 (1993).
    Article CAS Google Scholar
  7. Finken, M., Kirschner, P., Meier, A., Wrede, A. & Bottger, E.C. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: Alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol. Microbiol. 9, 1239–1246 (1993).
    Article CAS Google Scholar
  8. Mitchison, D.A. The action of antituberculosis drugs in short course chemotherapy. Tubercle 66, 219–225 (1985).
    Article CAS Google Scholar
  9. McCune, R.M., Tompsett, R. & McDermott, W. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by administration of pyrazinamide and a companion drug. J. Exp. Med. 104, 763–802 (1956).
    Article CAS Google Scholar
  10. Heifets, L. & Lindholm-Levy, P. Pyrazinamide sterilizing activity in vitro against semi-dormant Mycobacterium tuberculosis bacterial populations. Am. Rev. Respir. Dis. 145, 1223–1225 (1992).
    Article CAS Google Scholar
  11. Yeager, R.L., Munroe, W.G. & Dessau, F.I. Pyrazinamide (Aldinamide) in the treatment of pulmonary tuberculosis. Am. Rev. Tuberc. 65, 523–534 (1952).
    CAS PubMed Google Scholar
  12. Konno, K., Feldman, F.M. & McDermott, W. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am. Rev. Respir. Dis. 95, 461–469 (1967).
    CAS PubMed Google Scholar
  13. McClatchy, J.K., Tsang, A.Y. & Cernich, M.S. Use of pyrazinamidase activity in Mycobacterium tuberculosis as a rapid method for determination of pyrazinamide susceptibility. Antimicrob. Agent. Chemother. 20, 556–557 (1981).
    Article CAS Google Scholar
  14. Trivedi, S.S. & Desai, S.G. Pyrazinamidase activity of Mycobacterium tuberculosis — a test of sensitivity to pyrazinamide. Tubercle 68, 221–224 (1987).
    Article CAS Google Scholar
  15. Konno, K., Nagayama, H. & Oka, S. Nicotinamidase in mycobacteria: A method for distinguishing bovine type tubercle bacilli from other mycobacteria. Nature 184, 1743–1744 (1959).
    Article CAS Google Scholar
  16. Collins, C.H., Grange, J.M. & Yates, M.D. Tuberculosis Bacteriology. 59–66 (Butterworths, London, 1985).
    Google Scholar
  17. Foster, J.W. & Moat, A.G. Nicotinamide adenine dinucleotide biosynthesis and pyridine nucleotide cycle metabolism in microbial systems. Microbiol. Rev. 44, 83–105 (1980).
    CAS PubMed PubMed Central Google Scholar
  18. Bonicke, R. & Lisboa, B.P. Typendifferenzierung der Tuberkulosebakterien mit Hilfe des Nikotinamidasetests. Tuberkuloseartzt 13, 377 (1959).
    CAS Google Scholar
  19. Jerlstrom, P.G., Bezjak, D.A., Jennings, M.P. & Beacham, I.R. Structure and expression in Escherichia coli K-12 of the L-asparaginase I-encoding ansA gene and its flanking regions. Gene 78, 37–46 (1989).
    Article CAS Google Scholar
  20. Mackaness, G.B. The intracellular activation pyrazinamide and nicotinamide. Am. Rev. Tuberc. 74, 718–728 (1956).
    CAS PubMed Google Scholar
  21. Tarshis, M.S. & Weed, W.A. Lack of significant in vitro sensitivity of Mycobacterium tuberculosis to pyrazinamide on three different solid media. Am. Rev. Tuberc. 67, 391–395 (1953).
    CAS PubMed Google Scholar
  22. McDermott, W. & Tomsett, R. Activation of pyrazinamide and nicotinamide in acidic environment in vitro. Am. Rev. Tuberc. 70, 748–754 (1954).
    CAS PubMed Google Scholar
  23. Crowle, A.J., Dahl, R., Ross, E. & May, M.H. Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or M. avium in cultured human macrophages are not acidic. Infect. Immun. 59, 1823–1831 (1991).
    CAS PubMed PubMed Central Google Scholar
  24. World Health Organization. Zoonotic tuberculosis (Mycobacterium bovis): Memorandum from a WHO meeting. Bull. World Health Organ. 72, 851–857 (1994).
  25. Rodriguez, J.G., Mejia, G.A., Del Portillo, P., Patarroyo, M.E. & Murillo, L.A. Species-specific identification of Mycobacterium bovis by PCR. Microbiology. 141, 2131–2138 (1995).
    Article Google Scholar
  26. Orita, M., Suzuki, Y., Sekiya, T. & Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5, 874–879 (1989).
    Article CAS Google Scholar
  27. Dickinson, J.M. & Mitchison, D.A. Observation in vitro on the suitability of pyrazinamide for intermittent chemotherapy of tuberculosis. Tubercle 51, 389–396 (1970).
    Article CAS Google Scholar
  28. Klemens, S.P., Sharpe, C.A. & Cynamon, M.H. Activity of pyrazinamide in a murine model against Mycobacterium tuberculosis isolates with various levels of in vitro susceptibility. Antimicrob. Agent. Chemother. 40, 14–16 (1996).
    Article CAS Google Scholar
  29. Zhang, Y. et al. Alterations in the superoxide dismutase gene of an isoniazid-resistant strain of Mycobacterium tuberculosis. Infect. Immun. 60, 2160–2165 (1992).
    CAS PubMed PubMed Central Google Scholar
  30. Foster, J.W., Kinney, D.M. & Moat, A.G. Pyridine nucleotide cycle of Salmonella typhimurium: Isolation and characterization of pncA, pncB, and pncC mutants and utilization of exogenous nicotinamide adenine dinucleotide. J. Bacterial. 137, 1165–1175 (1979).
    CAS Google Scholar
  31. Saiki, R.K. et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487–491 (1988).
    Article CAS Google Scholar
  32. Sambrook, J., Fritsch, E.F. & Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd edn. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989).
    Google Scholar
  33. Garbe, T. et al. Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiology 140, 133–138 (1994).
    Article CAS Google Scholar
  34. Zhang, Y., Garbe, T. & Young, D. Transformation with katG restores isoniazid sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol. Microbiol. 8, 521–524 (1993).
    Article CAS Google Scholar
  35. Wayne, L.G. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am. Rev. Respir. Dis. 109, 147–151 (1974).
    CAS PubMed Google Scholar
  36. Skinner, P. et al. A bone marrow-derived macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions. Antimicrob. Agent. Chemother. 38, 2557–2563 (1994).
    Article CAS Google Scholar

Download references